本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Apogee Therapeutics

34.99
-2.8400-7.51%
盤後34.990.00000.00%17:12 EDT
成交量:71.71萬
成交額:2,516.59萬
市值:20.32億
市盈率:-10.60
高:36.74
開:36.22
低:33.58
收:37.83
資料載入中...
2024/03/25

重要事件披露

Form 8-K - Current report
2024/03/06

SEC問詢函

Form CORRESP - Correspondence
2024/03/06

SEC問詢函

Form CORRESP - Correspondence
2024/03/05

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2024/03/05

重要事件披露

Form 8-K - Current report
2024/03/05

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/05

重要事件披露

Form 8-K - Current report
2024/02/15

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/31

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/13

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13

重要事件披露

Form 8-K - Current report
2023/11/03

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/28

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/28

重要事件披露

Form 8-K - Current report
2023/08/21

重要事件披露

Form 8-K - Current report
2023/08/07

重要事件披露

Form 8-K - Current report
2023/07/28

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/07/24

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals